Treatment patterns and predictors of costs among patients with migraine: evidence from the United States medical expenditure panel survey

References

• Raval AD, Shah A. National trends in direct health care expenditures among US adults with migraine: 2004 to 2013. J Pain. 2017;18:96–107.
   PubMed Web of Science ®Google Scholar
• Burch RC, Loder S, Loder E, et al. The prevalence and burden of migraine and severe headache in the United States: updated statistics from government health surveillance studies. Headache. 2015;55:21–34.
   PubMed Web of Science ®Google Scholar
• Messali A, Sanderson JC, Blumenfeld AM, et al. Direct and indirect costs of chronic and episodic migraine in the United States: a web-based survey. Headache. 2016;56:306–322.
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33:629–808.
   PubMed Web of Science ®Google Scholar
• Abu Bakar N, Tanprawate S, Lambru G, et al. Quality of life in primary headache disorders: a review. Cephalalgia. 2016;36:67–91.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343–349.
   PubMed Web of Science ®Google Scholar
• Diener HC, Solbach K, Holle D, et al. Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options. Clin Med (Lond). 2015;15:344–350.
   PubMed Web of Science ®Google Scholar
• Merikangas KR. Contributions of epidemiology to our understanding of migraine. Headache. 2013;53:230–246.
   PubMed Web of Science ®Google Scholar
• Schwedt TJ. Chronic migraine. BMJ. 2014;348:g1416.
   PubMed Web of Science ®Google Scholar
• Giamberardino MA, Affaitati G, Martelletti P, et al. Impact of migraine on fibromyalgia symptoms. J Headache Pain. 2015;17:28.
   PubMed Web of Science ®Google Scholar
• Wang SJ, Chen PK, Fuh JL. Comorbidities of migraine. Front Neurol. 2010;1:16.
   PubMedGoogle Scholar
• Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52:1456–1470.
   PubMed Web of Science ®Google Scholar
• Smitherman TA, Burch R, Sheikh H, et al. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache. 2013;53:427–436.
   PubMed Web of Science ®Google Scholar
• Lanteri-Minet M. Economic burden and costs of chronic migraine. Curr Pain Headache Rep. 2014;18:385.
   PubMed Web of Science ®Google Scholar
• Ford JH, Jackson J, Milligan G, et al. A real-world analysis of migraine: a cross-sectional study of disease burden and treatment patterns. Headache. 2017;57:1532–1544.
   PubMed Web of Science ®Google Scholar
• Bonafede M, Cai Q, Cappell K, et al. Factors associated with direct health care costs among patients with migraine. J Manag Care Spec Pharm. 2017;23:1169–1176.
   PubMed Web of Science ®Google Scholar
• Stockbridge EL, Suzuki S, Pagan JA. Chronic pain and health care spending: an analysis of longitudinal data from the Medical Expenditure Panel Survey. Health Serv Res. 2015;50:847–870.
   PubMed Web of Science ®Google Scholar
• MEPS-HC Panel Design and Collection Process, Agency for Healthcare Research and Quality, Rockville, Md. [cited 2018 Jun 13]. Available from: https://meps.ahrq.gov/mepsweb/survey_comp/hc_data_collection.jsp
   Google Scholar
• Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology. 2008;71:1821–1828.
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)-revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005;25:460–465.
   PubMed Web of Science ®Google Scholar
• American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59:1–18.
   PubMed Web of Science ®Google Scholar
• Silberstein SD. Preventive migraine treatment. Continuum. 2015;21:973–989.
   PubMedGoogle Scholar
• Farley JF, Harley CR, Devine JW. A comparison of comorbidity measurements to predict healthcare expenditures. Am J Manag Care. 2006;12:110–119.
   PubMed Web of Science ®Google Scholar
• Fleishman JA, Cohen JW. Using information on clinical conditions to predict high-cost patients. Health Serv Res. 2010;45:532–552.
   PubMed Web of Science ®Google Scholar
• United States Department of Labor. Consumer Price Index. 2014 [cited 2018 Sep 21]. Available from: https://www.bls.gov/cpi/factsheets/medical-care.htm
   Google Scholar
• Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42:851–859.
   PubMed Web of Science ®Google Scholar
• National Vital Statistics Report. United States Life Tables. 2017. [cited 2018 Oct 21]. Available from: https://www.cdc.gov/nchs/data/nvsr/nvsr66/nvsr66_03.pdf
   Google Scholar
• Janet HF, Schroeder K, Nyhius AW, et al. Cycling through migraine preventive treatments: implications for all-cause total direct costs and disease-specific costs. J Manag Care Spec Pharm. 2019;25(1):46–59.
   PubMed Web of Science ®Google Scholar
• Shah AM, Bendtsen L, Zeeberg P, et al. Reduction of medication costs after detoxification for medication-overuse headache. Headache. 2013;53:665–672.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Serrano D, Nicholson RA, et al. Impact of NSAID and Triptan use on developing chronic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study. Headache. 2013;53:1548–1563.
   PubMed Web of Science ®Google Scholar
• Blumenfeld AM, Bloudek LM, Becker WJ, et al. Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the Second International Burden of Migraine Study (IBMS-II). Headache. 2013;53:644–655.
   PubMed Web of Science ®Google Scholar
• Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;41:638–645.
   PubMed Web of Science ®Google Scholar
• Hazard E, Munakata J, Bigal ME, et al. The burden of migraine in the United States: current and emerging perspectives on disease management and economic analysis. Value Health. 2009;12:55–64.
   PubMed Web of Science ®Google Scholar